CASMIR
The "CASMIR" trademark, serial number 77372317 , was filed on 15th of January 2008 with a mark drawing code of 4000 and its transaction date is 77372317. The attorney assigned is Maribeth Day Case, attorney docket number TMR/5040969/. Since 23rd of January 2012, the document can be found in the L80 law office in the publication and issue section. The employee responsible is WIENER, MICHAEL A and the date it was published for opposition on 09/30/2008. The status of this trademark was checked last on 01/23/2012.
The corresponded responsible for this trademark is MARIBETH DAY CASE, located at GLAXOSMITHKLINE, FIVE MOORE DRIVE, LGTM, C.3157.3D.The state or country where the trademark was organized is by Glaxo Group Limited. The legal entity type behing it is a Corporation, located at Berkeley Avenue, Greenford, Middlesex, zip UB60NN.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 01/18/2008 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 01/23/2012 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 01/23/2012 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 06/16/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 06/15/2011 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 06/14/2011 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 06/14/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 11/02/2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 11/01/2010 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 10/28/2010 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 10/28/2010 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 06/08/2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 06/07/2010 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 06/03/2010 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 06/03/2010 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 05/13/2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 05/03/2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 01/21/2010 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 12/03/2009 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 01/20/2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 12/03/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 10/24/2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 05/12/2009 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 05/12/2009 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 05/12/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 05/11/2009 | ATTORNEY REVOKED AND/OR APPOINTED | I - Incoming Correspondence | ARAA - ATTORNEY REVOKED AND/OR APPOINTED | |
| 05/11/2009 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | I - Incoming Correspondence | REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED | |
| 12/23/2008 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 09/30/2008 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 09/10/2008 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 08/28/2008 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 08/28/2008 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 08/20/2008 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 08/19/2008 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 08/19/2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 08/19/2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 04/25/2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 04/25/2008 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 04/25/2008 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 04/21/2008 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 01/18/2008 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "CASMIR" trademark, serial number 85485565 , was filed on 2nd of December 2011 with a mark drawing code of 4000 and its transaction date is 85485565. The attorney assigned is Maribeth Day Case, attorney docket number TMR/5082116/. Since 3rd of July 2012, the document can be found in the L90 law office in the publication and issue section. The employee responsible is MARCY, AMY ALFIERI and the date it was published for opposition on 05/08/2012. The status of this trademark was checked last on 07/03/2012.
The corresponded responsible for this trademark is MARIBETH DAY CASE, located at GLAXOSMITHKLINE, 5 MOORE DR, RESEARCH TRIANGLE PARK, NC 27709-0183.The state or country where the trademark was organized is by Glaxo Group Limited. The legal entity type behing it is a Corporation, located at Berkeley Avenue, Greenford, Middlesex, zip UB60NN.Other trademarks by this applicant: SPARQ, VARONEVE, BEDUA.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 12/07/2011 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
| TR0010 | The wording "CASMIR" has no meaning in a foreign language. |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 07/03/2012 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 05/08/2012 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 05/08/2012 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 04/18/2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
| 04/04/2012 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 04/03/2012 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 03/15/2012 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 03/14/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 12/07/2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 12/06/2011 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "CASMIR" trademark, serial number 85739904 , was filed on 27th of September 2012 with a mark drawing code of 4000 and its transaction date is 85739904. The attorney assigned is CECELIA M. PERRY, attorney docket number T21684-A. Since 12th of May 2014, the document can be found in the L30 law office in the publication and issue section. The employee responsible is KLINE, MATTHEW C and the date it was published for opposition on 03/05/2013. The status of the trademark was checked last on 05/12/2014.
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.